Annual Cash & Cash Equivalents
$342.49 M
+$79.31 M+30.13%
December 31, 2023
Summary
- As of February 7, 2025, NEO annual cash & cash equivalents is $342.49 million, with the most recent change of +$79.31 million (+30.13%) on December 31, 2023.
- During the last 3 years, NEO annual cash & cash equivalents has risen by +$113.78 million (+49.75%).
- NEO annual cash & cash equivalents is now at all-time high.
Performance
NEO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$361.99 M
+$6.91 M+1.95%
September 30, 2024
Summary
- As of February 7, 2025, NEO quarterly cash and cash equivalents is $361.99 million, with the most recent change of +$6.91 million (+1.95%) on September 30, 2024.
- Over the past year, NEO quarterly cash and cash equivalents has increased by +$19.50 million (+5.69%).
- NEO quarterly cash and cash equivalents is now -40.85% below its all-time high of $611.97 million, reached on March 31, 2021.
Performance
NEO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NEO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.1% | +5.7% |
| 3 y3 years | +49.8% | +6.3% |
| 5 y5 years | +3390.9% | +102.3% |
NEO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +30.1% | at high | +37.5% |
| 5 y | 5-year | at high | +98.0% | -40.9% | +319.7% |
| alltime | all time | at high | >+9999.0% | -40.9% | >+9999.0% |
NeoGenomics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $361.99 M(+1.9%) |
| Jun 2024 | - | $355.08 M(+7.0%) |
| Mar 2024 | - | $331.91 M(-3.1%) |
| Dec 2023 | $342.49 M(+30.1%) | $342.49 M(+11.8%) |
| Sep 2023 | - | $306.24 M(+5.9%) |
| Jun 2023 | - | $289.07 M(+4.9%) |
| Mar 2023 | - | $275.61 M(+4.7%) |
| Dec 2022 | $263.18 M(-16.9%) | $263.18 M(-1.1%) |
| Sep 2022 | - | $266.13 M(-6.2%) |
| Jun 2022 | - | $283.64 M(-7.3%) |
| Mar 2022 | - | $305.90 M(-3.5%) |
| Dec 2021 | $316.83 M(+38.5%) | $316.83 M(-7.0%) |
| Sep 2021 | - | $340.56 M(-7.7%) |
| Jun 2021 | - | $368.80 M(-39.7%) |
| Mar 2021 | - | $611.97 M(+167.6%) |
| Dec 2020 | $228.71 M(+32.2%) | $228.71 M(-1.9%) |
| Sep 2020 | - | $233.23 M(-21.0%) |
| Jun 2020 | - | $295.28 M(+242.3%) |
| Mar 2020 | - | $86.25 M(-50.1%) |
| Dec 2019 | $173.02 M(+1663.5%) | $173.02 M(-3.3%) |
| Sep 2019 | - | $178.89 M(+6.8%) |
| Jun 2019 | - | $167.44 M(+1168.9%) |
| Mar 2019 | - | $13.20 M(+34.5%) |
| Dec 2018 | $9.81 M(-23.5%) | $9.81 M(-91.7%) |
| Sep 2018 | - | $118.44 M(+1155.3%) |
| Jun 2018 | - | $9.44 M(-37.8%) |
| Mar 2018 | - | $15.17 M(+18.3%) |
| Dec 2017 | $12.82 M(+2.4%) | $12.82 M(+5.0%) |
| Sep 2017 | - | $12.21 M(+11.7%) |
| Jun 2017 | - | $10.93 M(-0.9%) |
| Mar 2017 | - | $11.04 M(-11.9%) |
| Dec 2016 | $12.53 M(-46.5%) | $12.53 M(-56.7%) |
| Sep 2016 | - | $28.93 M(+32.8%) |
| Jun 2016 | - | $21.79 M(+13.1%) |
| Mar 2016 | - | $19.26 M(-17.8%) |
| Dec 2015 | $23.42 M(-30.5%) | $23.42 M(-31.0%) |
| Sep 2015 | - | $33.97 M(+3.1%) |
| Jun 2015 | - | $32.95 M(+5.5%) |
| Mar 2015 | - | $31.25 M(-7.2%) |
| Dec 2014 | $33.69 M(+596.9%) | $33.69 M(-2.0%) |
| Sep 2014 | - | $34.37 M(+584.2%) |
| Jun 2014 | - | $5.02 M(-6.7%) |
| Mar 2014 | - | $5.38 M(+11.4%) |
| Dec 2013 | $4.83 M(+158.8%) | $4.83 M(-1.9%) |
| Sep 2013 | - | $4.93 M(+6.3%) |
| Jun 2013 | - | $4.64 M(+0.2%) |
| Mar 2013 | - | $4.63 M(+147.8%) |
| Dec 2012 | $1.87 M | $1.87 M(-8.3%) |
| Sep 2012 | - | $2.04 M(-20.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $2.57 M(-6.9%) |
| Mar 2012 | - | $2.76 M(+4.9%) |
| Dec 2011 | $2.63 M(+139.6%) | $2.63 M(-0.8%) |
| Sep 2011 | - | $2.65 M(+0.6%) |
| Jun 2011 | - | $2.63 M(+3.9%) |
| Mar 2011 | - | $2.53 M(+130.9%) |
| Dec 2010 | $1.10 M(-32.7%) | $1.10 M(-29.5%) |
| Sep 2010 | - | $1.55 M(-28.6%) |
| Jun 2010 | - | $2.18 M(+31.1%) |
| Mar 2010 | - | $1.66 M(+1.8%) |
| Dec 2009 | $1.63 M(+248.4%) | $1.63 M(-47.9%) |
| Sep 2009 | - | $3.13 M(+348.3%) |
| Jun 2009 | - | $697.70 K(-18.6%) |
| Mar 2009 | - | $857.20 K(+83.1%) |
| Dec 2008 | $468.20 K(+122.3%) | $468.20 K(-25.8%) |
| Sep 2008 | - | $631.40 K(+42.8%) |
| Jun 2008 | - | $442.20 K(+33.8%) |
| Mar 2008 | - | $330.40 K(+56.9%) |
| Dec 2007 | $210.60 K(+66.7%) | $210.60 K(-74.0%) |
| Sep 2007 | - | $809.90 K(-50.1%) |
| Jun 2007 | - | $1.62 M(+181.9%) |
| Mar 2007 | - | $575.40 K(+355.6%) |
| Dec 2006 | $126.30 K(+1058.7%) | $126.30 K(-69.3%) |
| Sep 2006 | - | $411.60 K(+50.0%) |
| Jun 2006 | - | $274.40 K(+5.5%) |
| Mar 2006 | - | $260.10 K(+2286.2%) |
| Dec 2005 | $10.90 K(-90.3%) | $10.90 K(-85.8%) |
| Sep 2005 | - | $76.80 K(+260.6%) |
| Jun 2005 | - | $21.30 K(-81.2%) |
| Mar 2005 | - | $113.00 K(+0.4%) |
| Dec 2004 | $112.50 K(+348.2%) | $112.50 K(-65.2%) |
| Sep 2004 | - | $323.60 K(+69.5%) |
| Jun 2004 | - | $190.90 K(+246.5%) |
| Mar 2004 | - | $55.10 K(+119.5%) |
| Dec 2003 | $25.10 K(-67.5%) | $25.10 K(-36.8%) |
| Sep 2003 | - | $39.70 K(+187.7%) |
| Jun 2003 | - | $13.80 K(+711.8%) |
| Mar 2003 | - | $1700.00(-92.8%) |
| Sep 2002 | - | $23.60 K(-33.3%) |
| Jun 2002 | - | $35.40 K(+3440.0%) |
| Mar 2002 | - | $1000.00(-98.7%) |
| Dec 2001 | $77.20 K(>+9900.0%) | $77.20 K(>+9900.0%) |
| Sep 2001 | - | $300.00(+200.0%) |
| Jun 2001 | - | $100.00(-80.0%) |
| Mar 2001 | - | $500.00(+150.0%) |
| Dec 2000 | $200.00 | $200.00(-94.7%) |
| Sep 2000 | - | $3800.00(+123.5%) |
| Jun 2000 | - | $1700.00(-63.8%) |
| Mar 2000 | - | $4700.00 |
FAQ
- What is NeoGenomics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for NeoGenomics?
- What is NeoGenomics annual cash & cash equivalents year-on-year change?
- What is NeoGenomics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for NeoGenomics?
- What is NeoGenomics quarterly cash and cash equivalents year-on-year change?
What is NeoGenomics annual cash & cash equivalents?
The current annual cash & cash equivalents of NEO is $342.49 M
What is the all time high annual cash & cash equivalents for NeoGenomics?
NeoGenomics all-time high annual cash & cash equivalents is $342.49 M
What is NeoGenomics annual cash & cash equivalents year-on-year change?
Over the past year, NEO annual cash & cash equivalents has changed by +$79.31 M (+30.13%)
What is NeoGenomics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NEO is $361.99 M
What is the all time high quarterly cash and cash equivalents for NeoGenomics?
NeoGenomics all-time high quarterly cash and cash equivalents is $611.97 M
What is NeoGenomics quarterly cash and cash equivalents year-on-year change?
Over the past year, NEO quarterly cash and cash equivalents has changed by +$19.50 M (+5.69%)